BOQI International Medical Enters into MOU to acquire Chongqing Shanfeng Zhiyuan Biotechnology

New York, May 18, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (BIMI or the Company) today announced that it has entered into a Memorandum of Understanding (MOU) to acquire Chongqing Shanfeng Zhiyuan Biotechnology Co., Ltd. (Chongqing Shanfeng Zhiyuan) through its wholly-owned subsidiary Beijing Xin Rong Xin Industrial Development Co., Ltd.